SCHEMBL853670

SCHEMBL853670

CCOC(=O)CC(c1ccccc1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
MTNR1A P48039 4/20 0.36
MTNR1B P49286 4/20 0.36
MGAM O43451 6/20 0.35
GAA P10253 6/20 0.35
SI P14410 6/20 0.35
MGAM2 Q2M2H8 6/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
KMT2A Q03164 2/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SCN9A Q15858 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGAV P06756 1/20 0.33
LTA4H P09960 1/20 0.33
PLA2G2A P14555 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853983 0.92 ITGB3 (0.35) NR1H2NR1H3MTNR1AMTNR1BMGAM
SCHEMBL853770 0.87 NR1H2 (0.36) NR1H2NR1H3MTNR1AMTNR1BMGAM
SCHEMBL853781 0.82 ITGB3 (0.51) MTNR1AMTNR1BTRPM8ITGB3ITGAV
SCHEMBL853915 0.80 HTT (0.35) MTNR1AMTNR1BTRPM8KMT2AMEN1
SCHEMBL854038 0.78 ITGB3 (0.48) ITGB3ITGAV
SCHEMBL852763 0.77 MGAM (0.45) MTNR1AMTNR1BMGAMGAASI
SCHEMBL853227 0.76 MGAM (0.44) MTNR1AMTNR1BMGAMGAASI
SCHEMBL861190 0.75 MAOA (0.42) NR1H2NR1H3MTNR1AMTNR1BITGB3
SCHEMBL854495 0.75 CCKBR (0.35) MTNR1AMTNR1BTRPM8KMT2AMEN1
SCHEMBL852713 0.75 ITGB3 (0.44) MTNR1AMTNR1BITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed